The HIV A (sor) gene product is essential for virus infectivity

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Nature

• Publication date

  1987-08-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/328728A0PMID 2441266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus

  1987cited by this paper
• Genome organization and transactivation of the human immunodeficiency virus type 2

  1987cited by this paper
• Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency.

  1986cited by this paper
• Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients.

  1986cited by this paper
• Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

  1986cited by this paper
• Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.

  1986cited by this paper
• Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.

  1986cited by this paper
• Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.

  1986cited by this paper
• A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.

  1986cited by this paper
• Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

  1985cited by this paper
• Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

  1985cited by this paper
• Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus.

  1985cited by this paper
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Molecular organization of the AIDS retrovirus.

  1985cited by this paper
• Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes.

  1985cited by this paper
• Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

  1985cited by this paper
• Nucleotide sequence of the AIDS virus, LAV.

  1985cited by this paper
• The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

  1982cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• ASCT2 inhibits HIV-1 infectivity by promoting the incorporation of a gp160/ASCT2 complex into virions

  2025cites this paper
• Rad18 suppresses the late step of human immunodeficiency virus type 1 replication

  2025cites this paper
• Host-Driven Ubiquitination Events in Vector-Transmitted RNA Virus Infections as Options for Broad-Spectrum Therapeutic Intervention Strategies

  2024cites this paper
• The Disassociation of A3G-Related HIV-1 cDNA G-to-A Hypermutation to Viral Infectivity

  2024cites this paper
• HIV-1 release requires Nef-induced caspase activation

  2023cites this paper
• Human Mannose Receptor 1 Attenuates HIV-1 Infectivity in a Virus Isolate-Specific Manner

  2023cites this paper
• HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton

  2023cites this paper
• Nanomedicines encountering HIV dementia: A guiding star for neurotherapeutics

  2022cites this paper
• The coevolution between APOBEC3 and retrotransposons in primates

  2022cites this paper
• The Myeloid-Specific Transcription Factor PU.1 Upregulates Mannose Receptor Expression but Represses Basal Activity of the HIV-LTR Promoter

  2022influential citation
• AIDS: The Long term disease

  2022cites this paper
• The Role of L-Selectin in HIV Infection

  2021cites this paper
• The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present

  2021cites this paper
• A Conserved uORF Regulates APOBEC3G Translation and Is Targeted by HIV-1 Vif Protein to Repress the Antiviral Factor

  2021cites this paper
• APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner

  2021cites this paper
• Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein

  2021cites this paper
• Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest

  2021cites this paper
• A conserved uORF impacts APOBEC3G translation and is essential for translational inhibition by the HIV-1 Vif protein

  2021cites this paper
• Bioisosteric Replacement as a Tool in Anti-HIV Drug Design

  2020cites this paper
• Engineered RNA-Interacting CRISPR Guide RNAs for Genetic Sensing and Diagnostics

  2020cites this paper
• Structural perspectives on HIV‐1 Vif and APOBEC3 restriction factor interactions

  2020cites this paper
• A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction

  2020cites this paper
• The Role of APOBECs in Viral Replication

  2020cites this paper
• HIV restriction factor APOBEC3G binds in multiple steps and conformations to search and deaminate single-stranded DNA

  2019cites this paper
• Diversity in APOBEC3 and CCR5 host genes and HIV-1 in a South African population

  2018cites this paper
• A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.

  2018cites this paper
• Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?

  2018cites this paper
• Maedi-visna virus as a model for HIV

  2018cites this paper
• Investigation of the HIV diversity in the Cape Winelands, Overberg and West Coast districts of the Western Cape Province of South Africa

  2017cites this paper
• Diversidad del VIH-1. Transmisión dinámica y resistencias primarias en los nuevos diagnósticos de VIH-1 en la población de Málaga (HUVV) durante los años 2004-2015.

  2017influential citation
• EPIGENETIC REGULATION OF HIV-1 LATENCY BY HISTONE H3 METHYLTRANSFERASES AND H3K27 DEMETHYLASE

  2017cites this paper
• APOBEC Enzymes as Targets for Virus and Cancer Therapy.

  2017cites this paper
• Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G

  2017cites this paper
• Long-term passage of Vif-null HIV-1 in CD4+ T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.

  2017cites this paper
• 7 Retroviral Host Cell Factors : TRIM 5 , APOBEC 3 G and Cyclophilins

  2017cites this paper
• Development of a viral and a non-viral based gene transfer systems using the yeast Saccharomyces cerevisiae

  2016cites this paper
• Investigating the feasibility of incorporating Vpx into lentiviral gene therapy vectors: at a global and targeted scale

  2016cites this paper
• Relations structure-fonction du premier transfert de brin chez le vih-1

  2016cites this paper
• Effet de la stimulation du TLR2 et de la sécrétion d'acétate sur la susceptibilité à l'infection au VIH-1 des lymphocytes T CD4+ primaires

  2016cites this paper
• 1,2,3-Triazoles as Amide Bioisosteres: Discovery of a New Class of Potent HIV-1 Vif Antagonists.

  2016cites this paper
• Intrinsic host restrictions to HIV-1 and mechanisms of viral escape

  2015cites this paper
• Heteroclitic human immunodeficiency virus peptides enhance HIV-specific CD8⁺ T cell proliferation and reduce PD-1 expression

  2015cites this paper
• Development of gold nanoparticle-based antigen delivery platform for vaccines against HIV-1

  2015cites this paper
• Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif

  2015cites this paper
• Recent advances in diagnosis of HIV and future prospects

  2015cites this paper
• Retroviral factors promoting infectivity.

  2015cites this paper
• An in silico approach for identification of novel inhibitors as a potential therapeutics targeting HIV-1 viral infectivity factor.

  2015cites this paper
• HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity

  2014cites this paper
• SHAPE Validated Secondary Structures of Mason-Pfizer Monkey Virus (MPMV) and Mouse Mammary Tumor Virus (MMTV) Packaging Signal RNAs Reveal Pal Helix Loops Functioning as Dimerization Initiation Sites (DIS) Controlling their Genomic RNA (gRNA) Packaging

  2014cites this paper
• Host Cell Factors in HIV-1 Replication Cycle

  2014cites this paper
• Caractérisation de l'interaction entre Gag(NCp7) et la protéine cellulaire RPL7 : aspects moléculaire et fonctionnel

  2014cites this paper
• Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.

  2014cites this paper
• Genomic HEXploring allows landscaping of novel potential splicing regulatory elements

  2014cites this paper
• The role of APOBEC3G in acute and early HIV-1 subtype C infection.

  2014cites this paper
• Inhibition of HIV-1 Vif by Pokeweed Antiviral Protein and its Impact on Cellular Immune Defense

  2014cites this paper
• Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition

  2014cites this paper
• Heat-Stable Molecule Derived from Streptococcus cristatus Induces APOBEC3 Expression and Inhibits HIV-1 Replication

  2014cites this paper
• Evaluation of the NIH clinical collection to identify potential HIV-1 integrase inhibitors

  2014cites this paper
• Structural insights for HIV-1 therapeutic strategies targeting Vif.

  2014cites this paper
• HIV-1 Viral Infectivity Factor Recruitment of Cellular Protein Complexes to Counter Host Antiviral Response

  2014cites this paper
• Suppression of APOBEC3-mediated restriction of HIV-1 by Vif

  2014cites this paper
• The Innate Immune Factor Apolipoprotein L1 Restricts HIV-1 Infection

  2013influential citation
• Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid binding protein

  2013cites this paper
• HLA-B51 associated HIV-1 viral control

  2013influential citation
• The APOBEC3 family of retroelement restriction factors.

  2013cites this paper
• Host Restriction of Lentiviruses and Viral Countermeasures: APOBEC3 and Vif

  2013cites this paper
• Restriction of Retrotransposition and Retroviral Infection by RNase L and APOBEC3G

  2013cites this paper
• HIV-1 Infection of T Cells and Macrophages Are Differentially Modulated by Virion-Associated Hck: A Nef-Dependent Phenomenon

  2013cites this paper
• Role of HIV-1 Vif in viral replication : translational regulation of APOBEC3G and RNA chaperone activity

  2013cites this paper
• Étude du rôle de la protéine Vpr du VIH-1 dans la modulation de la réponse immunitaire

  2013cites this paper
• Piezoelectric biosensors for molecular analysis in biomedical applications

  2013cites this paper
• Human Immunodeficiency Virus Reverse Transcriptase

  2013cites this paper
• Optical tweezers reveal how proteins alter replication

  2013cites this paper
• Regulation of human and HIV-1 splice sites

  2013cites this paper
• APOBECs and Their Role in Proviral DNA Synthesis

  2013cites this paper
• Feline restriction factors to lentiviral replication

  2013cites this paper
• Étude du mécanisme moléculaire d'incorporation de la molécule de l'hôte ICAM-1 par le VIH-1

  2013cites this paper
• HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors

  2013cites this paper
• Insights into the Dual Activity of SIVmac239 Vif against Human and African Green Monkey APOBEC3G

  2012cites this paper
• Infections lentivirales chez les petits ruminants domestiques : étude des relations hôte-pathogène et application en diagnostic

  2012cites this paper
• APOBEC3G Restricts HIV-1 to a Greater Extent than APOBEC3F and APOBEC3DE in Human Primary CD4+ T Cells and Macrophages

  2012cites this paper
• The role of Vif oligomerization and RNA chaperone activity in HIV-1 replication.

  2012cites this paper
• Control of Innate and Adaptive Immune Responses during Infectious Diseases

  2012cites this paper
• Flexible Viruses: Structural Disorder in Viral Proteins

  2012cites this paper
• Interaction of human immunodeficiency virus type 1 Vif with APOBEC3G is not dependent on serine/threonine phosphorylation status.

  2012cites this paper
• APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans

  2012cites this paper
• The Restriction Factors of Human Immunodeficiency Virus*

  2012cites this paper
• APOBEC 3 G Restricts HIV-1 to a Greater Extent than APOBEC 3 F and APOBEC 3 DE in Human Primary CD 4 T Cells and Macrophages

  2012cites this paper
• Sequence and structure requirements for specific recognition of HIV-1 TAR and DIS RNA by the HIV-1 Vif protein

  2012cites this paper
• The evaluation of gold-based compounds as potential inhibitors of HIV-1 replication.

  2012cites this paper
• The role of the rhesus macaque (macaca mulatta) apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) in lentiviral replication and persistence

  2012cites this paper
• Emerging Drug Targets for Antiretroviral Therapy

  2012cites this paper
• Antiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family

  2012influential citation
• SIV replication in human cells

  2012influential citation
• Protein intrinsic disorder as a flexible armor and a weapon of HIV-1

  2012cites this paper
• Running Loose or Getting Lost: How HIV-1 Counters and Capitalizes on APOBEC3-Induced Mutagenesis through Its Vif Protein

  2012cites this paper
• T Cell Responses During Human Immunodeficiency Virus (HIV)-1 Infection

  2012cites this paper
• Synthesis and Structure–Activity Relationship Studies of HIV‐1 Virion Infectivity Factor (Vif) Inhibitors that Block Viral Replication

  2012cites this paper
• A3G complexes: A novel role of A3G in restricting the late steps of HIV-1 replication

  2011cites this paper
• Making Order in the Intrinsically Disordered Regions of HIV‐1 Vif Protein

  2011cites this paper